162 related articles for article (PubMed ID: 31861173)
1. Development of a Resveratrol Nanosuspension Using the Antisolvent Precipitation Method without Solvent Removal, Based on a Quality by Design (QbD) Approach.
Kuk DH; Ha ES; Ha DH; Sim WY; Lee SK; Jeong JS; Kim JS; Baek IH; Park H; Choi DH; Yoo JW; Jeong SH; Hwang SJ; Kim MS
Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31861173
[TBL] [Abstract][Full Text] [Related]
2. Preparation and Characterization of Stable Nanosuspension for Dissolution Rate Enhancement of Furosemide: A Quality by Design (QbD) Approach.
Marzan AL; Tabassum R; Jahan B; Asif MH; Reza HM; Kazi M; Alshehri SM; de Matas M; Shariare MH
Curr Drug Deliv; 2018; 15(5):672-685. PubMed ID: 29359667
[TBL] [Abstract][Full Text] [Related]
3. Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box-Behnken design.
Hao J; Gao Y; Zhao J; Zhang J; Li Q; Zhao Z; Liu J
AAPS PharmSciTech; 2015 Feb; 16(1):118-28. PubMed ID: 25209687
[TBL] [Abstract][Full Text] [Related]
4.
Shariare MH; Altamimi MA; Marzan AL; Tabassum R; Jahan B; Reza HM; Rahman M; Ahsan GU; Kazi M
Saudi Pharm J; 2019 Jan; 27(1):96-105. PubMed ID: 30662312
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design.
Kassem MAA; ElMeshad AN; Fares AR
AAPS PharmSciTech; 2017 May; 18(4):983-996. PubMed ID: 27506564
[TBL] [Abstract][Full Text] [Related]
6. Quality by design-based optimization of formulation and process parameters for berberine nanosuspension for enhancing its dissolution rate, bioavailability, and cardioprotective activity.
Alsabeelah N; Kumar V
J Food Biochem; 2022 Oct; 46(10):e14361. PubMed ID: 35929374
[TBL] [Abstract][Full Text] [Related]
7. Formulation and Characterization of Ursodeoxycholic Acid Nanosuspension Based on Bottom-Up Technology and Box-Behnken Design Optimization.
Boscolo O; Flor S; Salvo L; Dobrecky C; Höcht C; Tripodi V; Moretton M; Lucangioli S
Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631251
[TBL] [Abstract][Full Text] [Related]
8. 24 Factorial Design Formulation Optimization and In vitro Characterization of Desloratadine Nanosuspension Prepared Using Antisolvent Precipitation.
El-Sebaiy MT; Alyami MH; Alyami HS; Kamal MA; Eissa N; Balata G; El-Nahas H
Curr Drug Deliv; 2024 Jun; ():. PubMed ID: 38867526
[TBL] [Abstract][Full Text] [Related]
9. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
Gajera BY; Shah DA; Dave RH
Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724
[TBL] [Abstract][Full Text] [Related]
10. Development of Atovaquone Nanosuspension: Quality by Design Approach.
Kakade P; Gite S; Patravale V
Curr Drug Deliv; 2020; 17(2):112-125. PubMed ID: 31880260
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of amorphous ezetimibe nanosuspensions intended for enhancement of oral bioavailability.
Thadkala K; Nanam PK; Rambabu B; Sailu C; Aukunuru J
Int J Pharm Investig; 2014 Jul; 4(3):131-7. PubMed ID: 25126526
[TBL] [Abstract][Full Text] [Related]
12. Increased Oral Bioavailability of Piperine from an Optimized Piper nigrum Nanosuspension.
Zafar F; Jahan N; ; Bhatti HN
Planta Med; 2019 Feb; 85(3):249-257. PubMed ID: 30357764
[TBL] [Abstract][Full Text] [Related]
13. Fabrication of isradipine nanosuspension by anti-solvent microprecipitation-high-pressure homogenization method for enhancing dissolution rate and oral bioavailability.
Shelar DB; Pawar SK; Vavia PR
Drug Deliv Transl Res; 2013 Oct; 3(5):384-91. PubMed ID: 25788346
[TBL] [Abstract][Full Text] [Related]
14. A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization.
Kola Srinivas NS; Verma R; Pai Kulyadi G; Kumar L
Int J Nanomedicine; 2017; 12():15-28. PubMed ID: 28031710
[TBL] [Abstract][Full Text] [Related]
15. Enhanced bioavailability of cinnarizine nanosuspensions by particle size engineering: Optimization and physicochemical investigations.
Mishra B; Sahoo J; Dixit PK
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():62-9. PubMed ID: 27040196
[TBL] [Abstract][Full Text] [Related]
16. Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies.
Patel HP; Chaudhari PS; Gandhi PA; Desai BV; Desai DT; Dedhiya PP; Vyas BA; Maulvi FA
Int J Pharm; 2021 May; 600():120474. PubMed ID: 33737093
[TBL] [Abstract][Full Text] [Related]
17. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Process and Formulation Parameters on the Fabrication of Efavirenz Nanosuspension to Improve Drug Solubility and Dissolution.
Rashed M; Dadashzadeh S; Bolourchian N
Iran J Pharm Res; 2022 Dec; 21(1):e129409. PubMed ID: 36942076
[TBL] [Abstract][Full Text] [Related]
19. A new nanosuspension prepared with wet milling method for oral delivery of highly variable drug Cyclosporine A: development, optimization and in vivo evaluation.
Pınar SG; Canpınar H; Tan Ç; Çelebi N
Eur J Pharm Sci; 2022 Apr; 171():106123. PubMed ID: 35017012
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of Stable Apigenin Nanosuspension with PEG 400 as Antisolvent for Enhancing the Solubility and Bioavailability.
Xu R; Jiang C; Zhou L; Li B; Hu Y; Guo Y; Xiao X; Lu S
AAPS PharmSciTech; 2021 Dec; 23(1):12. PubMed ID: 34881399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
